BioMimetic Q3 loss narrows

elawley@nashvillepost.com (Erin Lawley) — Fri, 06 Nov 2009 07:39:00 CST

Company starts enrolling for injectable product trials in Canada

Health Care Council hosting Swedish business delegation

elawley@nashvillepost.com (Erin Lawley) — Fri, 23 Oct 2009 12:15:00 CST

Group interested in Nashville health care innovations, relationships with local industry leaders

elawley@nashvillepost.com (Erin Lawley) — Wed, 14 Oct 2009 14:12:00 CST

Positive data from bone graft test gets Franklin company closer to crucial FDA approval

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Tue, 11 Aug 2009 06:20:42 CST

More Q2 beats from locals

walker.duncan@nashvillepost.com (Walker Duncan) — Mon, 06 Jul 2009 14:29:00 CST

Company led by Renal Care veteran hopes to finish out $2 million raise

Mon, 22 Jun 2009 00:04:00 CST

Sam Lynch has BioMimetic on a steady growth path. Next up: Two important product launches [From our print edition featured in Monday's City Paper]

walker.duncan@nashvillepost.com (Walker Duncan) — Thu, 07 May 2009 15:38:00 CST

Despite red ink on balance sheet, company tops analyst expectations

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Mon, 06 Apr 2009 19:00:59 CST

Private placement will be followed by larger rights offering

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Mon, 23 Mar 2009 06:23:00 CST

Lynch adopts trading plan to unload almost 1 percent of biotech's stock

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Thu, 18 Dec 2008 12:19:00 CST

Sector moves higher in part on lukewarm analyst calls